With the largest portfolio of any pharmaceutical company in the world, we are proud to deliver more than 3,500 different products to patients in more than 60 countries. Every day nearly 200 million people around the globe take a Teva medicine, while in the US alone, more than 1 million prescriptions are filled with a Teva product.
We invest significantly into research and development to help our scientists effectively bring medicines to market so that our product portfolio addresses the changing needs and challenges of healthcare. It is this research that forms the engine for growth and development, not only for our company, but as part of our aspiration to improve health. In developing these treatments – in the fields of respiratory, pain, migraine and headache, movement and neurodegenerative disorders, oncology and more – our number one priority is improving the lives of patients around the world.